← Back to Search

Download the REMAIN App for Human Immunodeficiency Virus Infection (EPI-LoVE Trial)

N/A
Recruiting
Led By Pamina Gorbach, DrPh
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

EPI-LoVE Trial Summary

Despite the widespread availability of effective antiretroviral therapy (ART) in the United States, there remains significant numbers of people living with HIV (PLWH) who fail to achieve and or maintain viral suppression (VS). Disparities persist with the lowest levels of VS among Black individuals, people who use drugs, youth ages 18-24 and people residing in rural areas. Investigators will examine the syndemics underlying these outcomes including substance use, mental health, and barriers to HIV care including racial discrimination, stigma and rural isolation.

EPI-LoVE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Incidence of HIV Viral Suppression
Level of Adherence based on HIV appointments
Level of Adherence to HIV medication

EPI-LoVE Trial Design

1Treatment groups
Experimental Treatment
Group I: Download the REMAIN AppExperimental Treatment1 Intervention
All participants download the app

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,533 Previous Clinical Trials
10,264,582 Total Patients Enrolled
University of North Carolina, Chapel HillOTHER
1,508 Previous Clinical Trials
4,189,825 Total Patients Enrolled
Florida State UniversityOTHER
200 Previous Clinical Trials
30,758 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~667 spots leftby Apr 2025